Content validity of signs and symptoms measures with the EORTC core module in women with locally advanced or metastatic breast cancer (MBC): A phase II trial with eribulin mesylate.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Author: W. Robert Simons
Institution: Eisai (United States)
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2992123728